TWiV 910: COVID-19 clinical update #119 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #119, Dr. Griffin reviews tixagevimab for infection prevention, ivermectin for outpatient infection treatment, symptom rebound after PAXLOVID treatment, bamlanivimab minimally impacting immune response to vaccination, in-hospital mortality among infection patients, residual viral antigen in patients following infection, usage of Casirvimab/Imdevimab and Remdesivir in infected patients with depleted B-cells, and rheumatic symptoms following infection.</p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3 id="links-for-this-episode"><strong>Links for this episode</strong></h3> <ul> <li><a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2116620?query=WB&cid=NEJM%20Weekend%20Briefing,%20June%2011,%202022%20DM1138551_NEJM_Non_Subscriber&bid=1021069048"> Tixagevimab-Cilgavimab</a> for infection prevention (NEJM)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v1">Ivermectin</a> for outpatient infection treatment (medRxiv)</li> <li>Symptom rebound after <a href= "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac481/6607746?redirectedFrom=fulltext&login=false">PAXLOVID treatment</a> (IDSA)</li> <li><a href= "https://www.science.org/doi/10.1126/scitranslmed.abn3041">Bamlanivimab minimally impacts</a> immune response to vaccination (Sci Transl Med)</li> <li>In-hospital <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofac278/6603477">morality among infected</a> patients (IDSA)</li> <li><a href= "https://academic.oup.com/ofid/articl